Achilles Therapeutics plc - American Depositary Shares (ACHL)

Achilles Therapeutics is a biotechnology company focused on developing innovative cancer therapies that harness the power of the immune system

The company specializes in creating personalized T-cell therapies, which are designed to target and destroy tumor cells by identifying unique neoantigens present in an individual’s cancer. By leveraging advances in genomics and immunotherapy, Achilles aims to improve treatment outcomes for patients with various types of cancer, while minimizing the side effects commonly associated with traditional treatments. Through its research and development efforts, the company is dedicated to transforming the landscape of cancer care.